Prac-tic

Negara: Uni Eropa

Bahasa: Inggris

Sumber: EMA (European Medicines Agency)

Beli Sekarang

Selebaran informasi Selebaran informasi (PIL)
06-09-2018
Karakteristik produk Karakteristik produk (SPC)
06-09-2018

Bahan aktif:

pyriprole

Tersedia dari:

Elanco GmbH

Kode ATC:

QP53AX26

INN (Nama Internasional):

pyriprole

Kelompok Terapi:

Dogs

Area terapi:

Ectoparasiticides for topical use, incl. insecticides

Indikasi Terapi:

Treatment and prevention of flea infestation (Ctenocephalides canis and C. felis) in dogs. Efficacy against new infestations with fleas persists for a minimum of 4 weeks.Treatment and prevention of tick infestation (Ixodes ricinus, Rhipicephalus sanguineus, Ixodes scapularis, Dermacentor reticulatus, Dermacentor variabilis, Amblyomma americanum) in dogs. Efficacy against ticks persists for 4 weeks.

Ringkasan produk:

Revision: 10

Status otorisasi:

Authorised

Tanggal Otorisasi:

2006-12-18

Selebaran informasi

                                33
B. PACKAGE LEAFLET
34
PACKAGE LEAFLET:
PRAC-TIC SPOT-ON SOLUTION FOR DOGS
1.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF
THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
RELEASE, IF DIFFERENT
Marketing authorisation holder:
Elanco GmbH
Heinz-Lohmann-Str. 4
27472 Cuxhaven
Germany
Manufacturer for the batch release:
Elanco France S.A.S.
26, Rue de la Chapelle
68330 Huningue
France
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Prac-tic 56.25 mg spot-on solution for very small dogs
Prac-tic 137.5 mg spot-on solution for small dogs
Prac-tic 275 mg spot-on solution for medium dogs
Prac-tic 625 mg spot-on solution for large dogs
Pyriprole
3.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENTS
One ml contains 125 mg pyriprole as a colourless to yellow, clear
solution for external application to
the skin.
One pipette delivers:
UNIT DOSE
PYRIPROLE
Prac-tic for very small dogs
0.45 ml
56.25 mg
Prac-tic for small dogs
1.1 ml
137.5 mg
Prac-tic for medium dogs
2.2 ml
275 mg
Prac-tic for large dogs
5.0 ml
625 mg
The solution also contains 0.1 % Butylhydroxytoluene (E321)
35
4.
INDICATION(S)
Treatment and prevention of flea infestation (
_Ctenocephalides_
_canis and C. felis_
.).
Treatment and prevention of tick infestation (
_Ixodes ricinus, Ixodes scapularis, Dermacentor _
_variabilis, Dermacentor reticulatus, Rhipicephalus sanguineus,
Amblyomma americanum_
).
Treatment and prevention of flea infestation: Prac-tic is effective
against new infestations with fleas
for a minimum duration of 4 weeks.
Treatment and prevention of tick infestation: Prac-tic is effective
against ticks for 4 weeks.
5.
CONTRAINDICATIONS
Do not use in dogs less than 8 weeks of age or weighing less than 2
kg.
Do not use in case of known hypersensitivity to phenylpyrazole class
compounds or to any of the
excipients.
Do not use on sick animals or on animals recovering from disease.
The veterinary medicinal product is specifically developed for dogs.
Do not use in cats, as this could lead to overdosing.
Do not use in rab
                                
                                Baca dokumen lengkapnya
                                
                            

Karakteristik produk

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Prac-tic 56.25 mg spot-on solution for very small dogs
Prac-tic 137.5 mg spot-on solution for small dogs
Prac-tic 275 mg spot-on solution for medium dogs
Prac-tic 625 mg spot-on solution for large dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One ml contains:
ACTIVE SUBSTANCE:
Pyriprole 125 mg
One pipette delivers:
UNIT DOSE
PYRIPROLE
Prac-tic for very small dogs
0.45 ml
56.25 mg
Prac-tic for small dogs
1.1 ml
137.5 mg
Prac-tic for medium dogs
2.2 ml
275 mg
Prac-tic for large dogs
5.0 ml
625 mg
EXCIPIENTS:
0.1% Butylhydroxytoluene (E321)
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Colourless to yellow, clear spot-on solution for external application
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dog
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment and prevention of flea infestation (
_Ctenocephalides_
_canis and C. felis_
) in dogs. Efficacy
against new infestations with fleas persists for a minimum of 4 weeks.
Treatment and prevention of tick infestation (
_Ixodes ricinus, Rhipicephalus sanguineus, Ixodes _
_scapularis, Dermacentor reticulatus, Dermacentor variabilis,
Amblyomma americanum_
) in dogs.
Efficacy against ticks persists for 4 weeks.
3
4.3
CONTRAINDICATIONS
Do not use in dogs less than 8 weeks of age or with a body weight of
less than 2 kg.
Do not use in cases of known hypersensitivity to phenylpyrazole class
compounds or to any of the
excipients.
Do not use on sick (e.g. systemic diseases, fever) animals or animals
recovering from disease.
This veterinary medicinal product is specifically developed for dogs.
Do not use in cats, as this could lead to overdosing.
Do not use in rabbits.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
This veterinary medicinal product is for the treatment of ticks and
adult fleas. All dogs in a household
should be treated.
In cases of heavy infestation prior to treatment, the dog’s
surrounding should be vacuumed and treated
with a suitable
                                
                                Baca dokumen lengkapnya
                                
                            

Dokumen dalam bahasa lain

Selebaran informasi Selebaran informasi Bulgar 06-09-2018
Karakteristik produk Karakteristik produk Bulgar 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Bulgar 27-09-2013
Selebaran informasi Selebaran informasi Spanyol 06-09-2018
Karakteristik produk Karakteristik produk Spanyol 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Spanyol 27-09-2013
Selebaran informasi Selebaran informasi Cheska 06-09-2018
Karakteristik produk Karakteristik produk Cheska 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Cheska 27-09-2013
Selebaran informasi Selebaran informasi Dansk 06-09-2018
Karakteristik produk Karakteristik produk Dansk 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Dansk 27-09-2013
Selebaran informasi Selebaran informasi Jerman 06-09-2018
Karakteristik produk Karakteristik produk Jerman 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Jerman 27-09-2013
Selebaran informasi Selebaran informasi Esti 06-09-2018
Karakteristik produk Karakteristik produk Esti 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Esti 27-09-2013
Selebaran informasi Selebaran informasi Yunani 06-09-2018
Karakteristik produk Karakteristik produk Yunani 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Yunani 27-09-2013
Selebaran informasi Selebaran informasi Prancis 06-09-2018
Karakteristik produk Karakteristik produk Prancis 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Prancis 27-09-2013
Selebaran informasi Selebaran informasi Italia 06-09-2018
Karakteristik produk Karakteristik produk Italia 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Italia 27-09-2013
Selebaran informasi Selebaran informasi Latvi 06-09-2018
Karakteristik produk Karakteristik produk Latvi 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Latvi 27-09-2013
Selebaran informasi Selebaran informasi Lituavi 06-09-2018
Karakteristik produk Karakteristik produk Lituavi 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Lituavi 27-09-2013
Selebaran informasi Selebaran informasi Hungaria 06-09-2018
Karakteristik produk Karakteristik produk Hungaria 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Hungaria 27-09-2013
Selebaran informasi Selebaran informasi Malta 06-09-2018
Karakteristik produk Karakteristik produk Malta 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Malta 27-09-2013
Selebaran informasi Selebaran informasi Belanda 06-09-2018
Karakteristik produk Karakteristik produk Belanda 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Belanda 27-09-2013
Selebaran informasi Selebaran informasi Polski 06-09-2018
Karakteristik produk Karakteristik produk Polski 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Polski 27-09-2013
Selebaran informasi Selebaran informasi Portugis 06-09-2018
Karakteristik produk Karakteristik produk Portugis 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Portugis 27-09-2013
Selebaran informasi Selebaran informasi Rumania 06-09-2018
Karakteristik produk Karakteristik produk Rumania 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Rumania 27-09-2013
Selebaran informasi Selebaran informasi Slovak 06-09-2018
Karakteristik produk Karakteristik produk Slovak 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Slovak 27-09-2013
Selebaran informasi Selebaran informasi Sloven 06-09-2018
Karakteristik produk Karakteristik produk Sloven 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Sloven 27-09-2013
Selebaran informasi Selebaran informasi Suomi 06-09-2018
Karakteristik produk Karakteristik produk Suomi 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Suomi 27-09-2013
Selebaran informasi Selebaran informasi Swedia 06-09-2018
Karakteristik produk Karakteristik produk Swedia 06-09-2018
Laporan Penilaian publik Laporan Penilaian publik Swedia 27-09-2013
Selebaran informasi Selebaran informasi Norwegia 06-09-2018
Karakteristik produk Karakteristik produk Norwegia 06-09-2018
Selebaran informasi Selebaran informasi Islandia 06-09-2018
Karakteristik produk Karakteristik produk Islandia 06-09-2018
Selebaran informasi Selebaran informasi Kroasia 06-09-2018
Karakteristik produk Karakteristik produk Kroasia 06-09-2018

Peringatan pencarian terkait dengan produk ini

Lihat riwayat dokumen